Higher income from investments and increased profits from associated companies helped Square Pharmaceuticals post a 26 percent year-on-year rise in net profit in the October-December period of fiscal year 2024-25.

The country's largest drugmaker recorded a profit of Tk 660 crore in the second quarter, up from Tk 524 crore in the same period a year ago.

Its revenue grew by 13 percent year-on-year to Tk 1,997 crore during the quarter. 

Meanwhile, the company's investment income surged by 51 percent, or Tk 54 crore, to Tk 159 crore, according to the company's financial report.

Square Pharmaceuticals' profit from associate undertakings rose 65 percent, or Tk 44 crore, to Tk 109 crore. 

The company has investments in three associates—Square Textile, Square Hospitals, and Square Fashions.

Additionally, it has investments in three subsidiaries—Square Pharmaceuticals Kenya EPZ, Square Lifesciences, and Samson Pharma.

Its earnings per share stood at Tk 7.45 in the second quarter, up from Tk 5.92 in the same period of the previous fiscal year.

On Thursday, Square Pharmaceuticals' stock declined 0.37 percent to Tk 216.